Practical Applied Genomics in Early Breast Cancer:
The Development and Validation of Oncotype DX

Norman Wolmark, M.D.

Chairman and Principal Investigator of the National Surgical Adjuvant Breast and Bowel Project (NSABP),
Professor and Chairman of Human Oncology, Drexel University School of Medicine Philadelphia, Pennsylvania.

 

 

TAILORx and the Power of Prospective Outcomes Data

Steve Shak, M.D.

Executive Vice President of Research and Development, Genomic Health Inc.

 

 

 

Real-life Analysis Evaluating Treatments and Outcomes in Clalit Breast Cancer Patients for whom Adjuvant Treatment Decisions Incorporated the 21-gene Recurrence Score Results (Median Follow-up >5 Years)

Salomon M. Stemmer, M.D.

Head, Research Unit, Institute of Oncology, Davidoff Center, Rabin Medical Center. Affiliated to the Sackler Faculty of Medicine.